United States · FDA National Drug Code directory

Cephalexin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
80425-0004_137a5de3-ab83-e2ab-e063-6294a90a6209
Product NDC
80425-0004
Form
CAPSULE
Composition / generic term
Cephalexin
Labeler
ADVANCED RX PHARMACY OF TENNESSEE, LLC
Marketing category
ANDA
Marketing start / end (source format)
20220914
Source listing expiry
20261231

Source-listed ingredients

  • CEPHALEXIN — 500 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 28 CAPSULE in 1 BOTTLE (80425-0004-1) · 80425-0004-1
  • 40 CAPSULE in 1 BOTTLE (80425-0004-2) · 80425-0004-2
  • 6 CAPSULE in 1 BOTTLE (80425-0004-3) · 80425-0004-3
  • 5 CAPSULE in 1 BOTTLE (80425-0004-4) · 80425-0004-4
  • 14 CAPSULE in 1 BOTTLE (80425-0004-5) · 80425-0004-5
  • 20 CAPSULE in 1 BOTTLE (80425-0004-6) · 80425-0004-6
  • 30 CAPSULE in 1 BOTTLE (80425-0004-7) · 80425-0004-7

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →